CVS Health Corp (CVS)
$56.01
0.26 (0.46%)
CVS Stock Quote Delayed 15 Minutes
Previous Close
$56.27
Market Cap
56.94B
PE Ratio
8.60
EPS
6.51
Volume (Avg. Vol.)
1,030
Day's Range
55.05 - 56.40
52-Week Range
51.72 - 82.15
Dividend & Yield
2.00 (3.57%)
CVS Stock Predictions, Articles, and CVS Health Corp News
The Worst Appears to Be Over for CVS Stock
Over the years, CVS stock has incurred some painful losses in the markets. However, bold moves by management make this a compelling contrarian buy.
CVS Stock Will Come Back Strong, but Be Wary of Upcoming Earnings
Long-term shareholders in the retail pharma giant CVS stock are likely to be rewarded handsomely
Right Now It Looks as If It Is Time for CVS Stock to Breakout Higher
The multi year sell-off in CVS stock may be coming to an end, and what comes next could be a big rally.
A Pairs Prescription for CVS Stock and Merck
Longstanding cycles in CVS Health and Merck are at risk of changing and offering profits to spread traders buying CVS stock and shorting MRK.
CVS Stock Is a Buy as It Prepares to Take on Private Insurance
CVS gained cash flow with Aetna. It is now focused on cutting the costs of serving those patients with its HealthHubs.
Friday’s Vital Data: Bed Bath & Beyond, CVS and Merck
Options trading was buzzing in Bed Bath & Beyond, CVS, and Merck on Thursday. Here are the metrics that matter moving forward.
3 Big Stock Charts for Friday: HollyFrontier, Activision Blizzard and Vertex Pharmaceuticals
The stock charts of HollyFrontier, Activision Blizzard and Vertex Pharmaceuticals are poised to end the trading week in a pivotal situation.
Nasdaq Today: Biotech Wrecked; Buy Microsoft?
Investors saw new highs in the Nasdaq today, but the index finished slightly lower on the day. Here's what we're watching now.
If Everything is Going Wrong for CVS Health Stock, is That a Buy Signal?
CVS Health has no shortage of risks. But a cheap valuation and long-term opportunities suggest the CVS stock sell-off has gone too far.
Should Debt Hold You Back From Buying CVS Stock? We’re Of Several Opinions
CVS Health added a lot of debt when it acquired Aetna for $69 billion. Should the company's balance sheet hold you back from buying CVS stock?
3 Big Stock Charts for Wednesday: CVS Health, Pfizer and Weyerhaeuser
The stock charts of CVS Health, Pfizer and Weyerhaeuser head into the midpoint of the week on the verge of major moves.
CVS Stock Is Cheap for a Reason
CVS stock trades at a low multiple, and this will likely remain the case until management can restore confidence in CVS Health stock.
CVS Health Stock Has Cannibalized Itself
It seems like everywhere I go, there is a CVS. The company may have over-extended itself, which is bad news for CVS stock holders.
CVS Stock Has More Going for It Than Just a 3.69% Dividend Yield
A judge is challenging the CVS Health-Aetna deal and the drug store sector is out of favor. So when will the discount on CVS stock end?
Aetna Uncertainty Is Keeping CVS Stock Way Undervalued
It admittedly takes some guts to step into CVS stock here, in the middle of a renewed legal mess, but that's exactly the time to go bargain hunting.
Can CVS Stock Overcome the Latest Wrench in Its Aetna Merger?
Senior Judge Leon objects to an insurer owning a PBM, but UnitedHealth, Centene and Cigna already do. How will this affect CVS stock?
CBD Products May Offer the Competitive Edge to Move Kroger Stock Higher
Recent reports say that Kroger will start selling CBD products at almost 1,000 of its stores. Will it be enough to boost Kroger stock?
5 Must-See Stock Charts for Wednesday: S, BB, CVS, BYND
GrubHub, BlackBerry, CVS Health, Sprint and Beyond Meat are our must-see stock charts going into Wednesday.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
C
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!
